Johnson & Johnson Earnings
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 13, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$2.53
Johnson & Johnson earnings summary
Johnson & Johnson is scheduled to report Sep/2026 earnings on Oct 13, 2026 before the market opens, with analysts expecting EPS of $2.53. In its most recent report on Jul 23, 2026 (Q2 2026), JNJ posted EPS of $2.27. Revenue for the quarter was $25.31 billion.
Quarterly EPS is down 0.9% from the same quarter a year earlier. Across the last 16 reports, JNJ shares moved an average of 1.7% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
JNJ earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 23, 2026 | — | $2.27 | — | -2.7% |
| Apr 22, 2026 | — | $2.14 | — | -0.1% |
| Feb 11, 2026 | — | $2.08 | — | -0.4% |
| Oct 22, 2025 | — | $2.12 | — | -0.8% |
| Jul 24, 2025 | — | $2.29 | — | -0.6% |
| Apr 23, 2025 | — | $4.54 | — | +1.0% |
| Feb 13, 2025 | — | $1.41 | — | +3.9% |
| Oct 23, 2024 | — | $1.11 | — | -0.5% |
| Jul 25, 2024 | — | $1.93 | — | +2.2% |
| May 1, 2024 | — | $1.34 | — | +0.4% |
| Feb 16, 2024 | — | $1.67 | — | +3.4% |
| Oct 27, 2023 | — | $10.21 | — | +3.9% |
| Jul 31, 2023 | — | $1.96 | — | +2.8% |
| Apr 28, 2023 | — | $-0.03 | — | -0.6% |
| Oct 27, 2022 | — | $1.68 | — | -1.9% |
| Jul 29, 2022 | — | $1.80 | — | -2.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.